BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Operating Leases (2019 - 2026)

Updated

BioLineRx (BLRX) posted Operating Leases of $962,000 for the quarter ended Jun 30, 2026, down 3.6% from $998,000 a year earlier and down 1.7% from the prior quarter.

Analysis

BioLineRx (BLRX) Operating Leases (2019 - 2026) Analysis & Trends

As of Dec 31, 2025, BioLineRx's Operating Leases came in at $977,000, down 9.6% from the prior year.

  • Annual Operating Leases has declined for three consecutive years, with a five-year compound annual growth rate of -10.1% (years ended Dec 2020 to Dec 2025).
  • In prior years, BioLineRx's Operating Leases was $1.08 million in the year ended Dec 31, 2024 (-16.2%), $1.29 million in the year ended Dec 31, 2023 (-25.4%), $1.73 million in the year ended Dec 31, 2022 (+0.2%) and $1.73 million in the year ended Dec 31, 2021 (+3.9%).
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Operating Leases since the quarter ended Mar 31, 2022.
  • On a year-over-year basis, Operating Leases has declined in each of the last seven quarters, with an average decline of 11.6% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Leases in the past five years was the quarter ended Sep 30, 2022, with growth of 791.7%; the weakest was the quarter ended Mar 31, 2024, with a decline of 27.8%.
  • According to Business Quant data, Operating Leases for the three prior quarters was $979,000 (quarter ended Mar 31, 2026), $977,000 (quarter ended Dec 31, 2025) and $1 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 962,000.00
Mar 31, 2026 979,000.00
Dec 31, 2025 977,000.00
Sep 30, 2025 1.00 Mn
Jun 30, 2025 998,000.00
Mar 31, 2025 985,000.00
Dec 31, 2024 1.08 Mn
Sep 30, 2024 1.29 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 1.23 Mn
Dec 31, 2023 1.29 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 1.59 Mn
Mar 31, 2023 1.70 Mn
Dec 31, 2022 1.73 Mn
Sep 30, 2022 1.51 Mn
Jun 30, 2022 1.45 Mn
Mar 31, 2022 147,000.00
Dec 31, 2021 1.73 Mn
Sep 30, 2021 169,000.00
API Access

BioLineRx Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BLRX&period=max&api_key=YOUR_API_KEY